HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.

Abstract
The importance of heart rate for left ventricular remodeling and prognosis after myocardial infarction is not known. We examined the contribution of heart rate reduction by zatebradine, a direct sinus node inhibitor without negative inotropic effects on left ventricular function and dilatation, on mortality, energy metabolism, and neurohormonal changes in rats with experimental myocardial infarction (MI). Thirty minutes after left coronary artery ligation or sham operation, the rats were randomized to receive either placebo or zatebradine (100 mg x kg(-1) x day(-1) per gavage) continued for 8 wk. Mortality during 8 wk was 33.3% in the placebo and 23.0% in the zatebradine group (P < 0.05); MI size was 36 +/- 2% and 30 +/- 1% (means +/- SE, P < 0.05), respectively. Zatebradine improved stroke volume index in all treated rats but increased left ventricular volume in rats with small MI (2.43 +/- 0.10 vs. 1.81 +/- 0.10 ml/kg, P < 0.05) but not in rats with large MI (2.34 +/- 0.09 vs. 2.35 +/- 0.11 ml/kg, not significant). Zatebradine reduced left and right ventricular norepinephrine and increased left and right ventricular 3,4-dihydroxyphenyl ethylene glycol-to-norepinephrine ratio suggesting aggravation of cardiac sympathetic activation by zatebradine after MI. Creatine kinase and lactate dehydrogenase isoenzymes in rats with MI remained unchanged by zatebradine. Lowering heart rate per se reduces mortality and MI size in this model but induces adverse effects on left ventricular remodeling in rats with small MI.
AuthorsKai Hu, Anne Naumann, Daniela Fraccarollo, Peter Gaudron, Jens J Kaden, Stefan Neubauer, Georg Ertl
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 286 Issue 4 Pg. H1281-8 (Apr 2004) ISSN: 0363-6135 [Print] United States
PMID15020301 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzazepines
  • Cardiotonic Agents
  • Catecholamines
  • Hormones
  • Isoenzymes
  • L-Lactate Dehydrogenase
  • Creatine Kinase
  • zatebradine
Topics
  • Animals
  • Benzazepines (pharmacology)
  • Body Weight (drug effects)
  • Cardiotonic Agents (pharmacology)
  • Catecholamines (blood)
  • Chromatography, High Pressure Liquid
  • Creatine Kinase (metabolism)
  • Dilatation, Pathologic (prevention & control)
  • Dose-Response Relationship, Drug
  • Energy Metabolism (drug effects)
  • Female
  • Heart Rate (drug effects)
  • Hemodynamics (drug effects)
  • Hormones (blood)
  • Isoenzymes (metabolism)
  • L-Lactate Dehydrogenase (metabolism)
  • Myocardial Infarction (mortality, pathology, prevention & control)
  • Myocardium (enzymology)
  • Oxygen Consumption (drug effects)
  • Rats
  • Rats, Wistar
  • Ventricular Function, Left (drug effects)
  • Ventricular Remodeling (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: